TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0%
Tue, 27 Oct

TORRENT PHARMA has announced its results for the quarter ended September 2020. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-19*
3
Jun-20*
3
Sep-20*
QoQ ChangeYoY Change
Net SalesRs m20,05020,56020,170-1.9%0.6%
Other incomeRs m340406050.0%-82.4%
TurnoverRs m20,39020,60020,230-1.8%-0.8%
ExpensesRs m14,64013,95013,820-0.9%-5.6%
Gross profitRs m5,4106,6106,350-3.9%17.4%
DepreciationRs m1,6301,6101,6502.5%1.2%
InterestRs m1,1601,020920-9.8%-20.7%
Profit before taxRs m2,9604,0203,840-4.5%29.7%
TaxRs m520810740-8.6%42.3%
Profit after taxRs m2,4403,2103,100-3.4%27.0%
Gross profit margin%27.032.131.5
Effective tax rate%17.620.119.3
Net profit margin%12.015.615.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 0.6% on a year-on-year (YoY) basis. The expenses were down by 5.6% YoY during the same period.
  • The company's operating profit increased by 17.4% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 31.5% in 2QFY21 as against 27.0% in 2QFY20.
  • Depreciation charges increased by 1.2% and finance costs declined by 20.7% YoY, respectively.
  • Other income declined by 82.4% YoY during the quarter.
  • Net profit for the quarter increased by 27.0% YoY. Net profit margins during the quarter increased from 12.0% in 2QFY20 to 15.3% in 2QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 1.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 0.9% QoQ during the same period.
  • The company's operating profit declined by 3.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 31.5% in 2QFY21 as against 32.1% in 1QFY20.
  • Net profit for the quarter declined by 3.4% QoQ, while net profit margins declined from 15.6% in 1QFY20 to 15.3% in 2QFY21.

To see how TORRENT PHARMA has performed over the last eight quarters,please visit here.

Discover Now: One Stock for Potentially Life-changing Gains

TORRENT PHARMA Share Price Performance

Over the last one year, TORRENT PHARMA share price has moved up from Rs 1,742.4 to Rs 2,565.6, registering a Gain of Rs 823.2 or around 47.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,387.8 (up 0.1%). Over the last one year it has moved up from 12,984.8 to 19,387.8, a gain of 6,403 points (up 49.3%).

Overall, the S&P BSE SENSEX is up 3.0% over the year.

Current Valuations

At the current price of Rs 2,565.6, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 36.3 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 9.2 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


May 7, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - TEVA PHARMA COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS